CRDF Stock-Based Compensation
Cardiff Oncology Inc · Stock-Based Compensation
CRDF Stock-Based Compensation
Latest reported$920.00Kperiod ending
CRDF Quarterly Stock-Based Comp ($0.00 → $920.00K)
Quarterly stock-based compensation
High-resolution chart · PNG
CRDF stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 920,000 | |
| 1,660,000 | |
| 1,261,000 | |
| 1,384,000 | |
| 1,683,000 | |
| 1,365,000 | |
| 1,204,000 | |
| 1,253,000 | |
| 1,179,000 | |
| 1,124,000 | |
| 909,000 | |
| 955,000 | |
| 1,581,000 | |
| 1,064,000 | |
| 1,012,000 | |
| 1,037,000 | |
| 1,055,000 | |
| 1,152,000 | |
| 990,000 | |
| 940,000 | |
| 1,036,000 | |
| 268,000 | |
| 943,835 | |
| 0 | |
| 0 | |
| 177,000 | |
| 269,717 | |
| 266,325 | |
| 149,000 | |
| 200,000 | |
| 268,975 | |
| 278,221 | |
| 221,300 | |
| 1,406,131 | |
| 895,221 | |
| 1,421,180 | |
| 775,385 | |
| 920,799 | |
| 1,561,924 | |
| 1,829,371 | |
| 1,301,913 | |
| 2,811,108 | |
| 1,187,180 | |
| 923,660 | |
| 1,123,446 | |
| 711,741 | |
| 685,235 | |
| 405,699 | |
| 419,487 | |
| 559,773 | |
| 122,680 | |
| 969,076 | |
| 347,342 | |
| 540,266 | |
| 183,130 | |
| 130,360 | |
| 115,820 | |
| 102,830 | |
| 47,303 | |
| 82,970 | |
| 56,545 | |
| 64,160 | |
| 0 | |
| 0 | |
| 0 | |
| 2,006 | |
| 2,006 | |
| 555,659 | |
| 3,590,630 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |